“Weill Cornell Medical College in New York City, a Cornell University college, has been awarded a $100,000 grant from the New York City Economic Development Corp. and Mayor Michael Bloomberg’s administration for a clinical study to test the effectiveness of the smart pill bottle on drug adherence in HIV-positive patients. It was one of 10 partnerships to win an inaugural PILOT Health Tech NYC grant.
The smart bottle is made by AdhereTech, a startup firm that licensed the technology from UAH (University of Alabama in Huntsville), which holds an equity position in the company.
For 12 weeks, the New York trial is scheduled to follow 70 HIV patients with medication compliance difficulties who are being treated at Weill Cornell. Each patient will receive adherence counseling, but only half will also use the smart pill bottles.”
I first mentioned the AdhereTech bottle back in March of this year. Then I mentioned it again during a presentation that I gave in May at the HIMSS Southern California Chapter 5th Annual Clinical Informatics Summit: Adventures in Clinical Informatics. It’s an interesting piece of technology. I’m curious to see what the outcome of the study shows.